BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22485232)

  • 1. Procalcitonin is a good tool to guide duration of antibiotic therapy in patients with severe acute pancreatitis. A randomized prospective single-center controlled trial.
    Qu R; Ji Y; Ling Y; Ye CY; Yang SM; Liu YY; Yang RY; Luo YF; Guo Z
    Saudi Med J; 2012 Apr; 33(4):382-7. PubMed ID: 22485232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial.
    Hochreiter M; Köhler T; Schweiger AM; Keck FS; Bein B; von Spiegel T; Schroeder S
    Crit Care; 2009; 13(3):R83. PubMed ID: 19493352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of procalcitonin-guided decision-making to shorten antibiotic therapy in suspected neonatal early-onset sepsis: prospective randomized intervention trial.
    Stocker M; Fontana M; El Helou S; Wegscheider K; Berger TM
    Neonatology; 2010; 97(2):165-74. PubMed ID: 19776651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study.
    Schroeder S; Hochreiter M; Koehler T; Schweiger AM; Bein B; Keck FS; von Spiegel T
    Langenbecks Arch Surg; 2009 Mar; 394(2):221-6. PubMed ID: 19034493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial.
    Schuetz P; Christ-Crain M; Wolbers M; Schild U; Thomann R; Falconnier C; Widmer I; Neidert S; Blum CA; Schönenberger R; Henzen C; Bregenzer T; Hoess C; Krause M; Bucher HC; Zimmerli W; Müller B;
    BMC Health Serv Res; 2007 Jul; 7():102. PubMed ID: 17615073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procalcitonin-based therapeutic strategy to reduce antibiotic use in patients after cardiac surgery: a randomized controlled trial.
    Maravić-Stojković V; Lausević-Vuk L; Jović M; Ranković A; Borzanović M; Marinković J
    Srp Arh Celok Lek; 2011; 139(11-12):736-42. PubMed ID: 22338468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: a randomized noninferiority trial.
    Verduri A; Luppi F; D'Amico R; Balduzzi S; Vicini R; Liverani A; Ruggieri V; Plebani M; Barbaro MP; Spanevello A; Canonica GW; Papi A; Fabbri LM; Beghè B;
    PLoS One; 2015; 10(3):e0118241. PubMed ID: 25760346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial.
    Nobre V; Harbarth S; Graf JD; Rohner P; Pugin J
    Am J Respir Crit Care Med; 2008 Mar; 177(5):498-505. PubMed ID: 18096708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic treatment interruption of suspected lower respiratory tract infections based on a single procalcitonin measurement at hospital admission--a randomized trial.
    Kristoffersen KB; Søgaard OS; Wejse C; Black FT; Greve T; Tarp B; Storgaard M; Sodemann M
    Clin Microbiol Infect; 2009 May; 15(5):481-7. PubMed ID: 19416298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial.
    Schuetz P; Christ-Crain M; Thomann R; Falconnier C; Wolbers M; Widmer I; Neidert S; Fricker T; Blum C; Schild U; Regez K; Schoenenberger R; Henzen C; Bregenzer T; Hoess C; Krause M; Bucher HC; Zimmerli W; Mueller B;
    JAMA; 2009 Sep; 302(10):1059-66. PubMed ID: 19738090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis. A randomized controlled trial.
    Shehabi Y; Sterba M; Garrett PM; Rachakonda KS; Stephens D; Harrigan P; Walker A; Bailey MJ; Johnson B; Millis D; Ding G; Peake S; Wong H; Thomas J; Smith K; Forbes L; Hardie M; Micallef S; Fraser JF; ;
    Am J Respir Crit Care Med; 2014 Nov; 190(10):1102-10. PubMed ID: 25295709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procalcitonin-guided antibiotic therapy in aspiration pneumonia and an assessment of the continuation of oral intake.
    Ogasawara T; Umezawa H; Naito Y; Takeuchi T; Kato S; Yano T; Kasamatsu N; Hashizume I
    Respir Investig; 2014 Mar; 52(2):107-13. PubMed ID: 24636266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procalcitonin versus C-reactive protein for guiding antibiotic therapy in sepsis: a randomized trial.
    Oliveira CF; Botoni FA; Oliveira CR; Silva CB; Pereira HA; Serufo JC; Nobre V
    Crit Care Med; 2013 Oct; 41(10):2336-43. PubMed ID: 23921272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and economic impact of procalcitonin to shorten antimicrobial therapy in septic patients with proven bacterial infection in an intensive care setting.
    Deliberato RO; Marra AR; Sanches PR; Martino MD; Ferreira CE; Pasternak J; Paes AT; Pinto LM; dos Santos OF; Edmond MB
    Diagn Microbiol Infect Dis; 2013 Jul; 76(3):266-71. PubMed ID: 23711530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A procalcitonin-based guideline promotes shorter duration of antibiotic use safely in acute pancreatitis.
    Cai Y; Ee J; Liew YX; Lee W; Chlebicki MP; Goh YC; Kwa AL
    J Infect; 2014 Oct; 69(4):412-5. PubMed ID: 24968241
    [No Abstract]   [Full Text] [Related]  

  • 16. Procalcitonin usefulness for the initiation of antibiotic treatment in intensive care unit patients.
    Layios N; Lambermont B; Canivet JL; Morimont P; Preiser JC; Garweg C; Ledoux D; Frippiat F; Piret S; Giot JB; Wiesen P; Meuris C; Massion P; Leonard P; Nys M; Lancellotti P; Chapelle JP; Damas P
    Crit Care Med; 2012 Aug; 40(8):2304-9. PubMed ID: 22809906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Procalcitonin Measurement and Viral Testing to Guide Antibiotic Use for Respiratory Infections in Hospitalized Adults: A Randomized Controlled Trial.
    Branche AR; Walsh EE; Vargas R; Hulbert B; Formica MA; Baran A; Peterson DR; Falsey AR
    J Infect Dis; 2015 Dec; 212(11):1692-700. PubMed ID: 25910632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute exacerbations of chronic obstructive pulmonary disease with low serum procalcitonin values do not benefit from antibiotic treatment: a prospective randomized controlled trial.
    Wang JX; Zhang SM; Li XH; Zhang Y; Xu ZY; Cao B
    Int J Infect Dis; 2016 Jul; 48():40-5. PubMed ID: 27155210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procalcitonin variations after Emergency Department admission are highly predictive of hospital mortality in patients with acute infectious diseases.
    Magrini L; Travaglino F; Marino R; Ferri E; De Berardinis B; Cardelli P; Salerno G; Di Somma S
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17 Suppl 1():133-42. PubMed ID: 23436675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excluding infection through procalcitonin testing improves outcomes of congestive heart failure patients presenting with acute respiratory symptoms: results from the randomized ProHOSP trial.
    Schuetz P; Kutz A; Grolimund E; Haubitz S; Demann D; Vögeli A; Hitz F; Christ-Crain M; Thomann R; Falconnier C; Hoess C; Henzen C; Marlowe RJ; Zimmerli W; Mueller B;
    Int J Cardiol; 2014 Aug; 175(3):464-72. PubMed ID: 25005339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.